Ms. Birgit Stattin Norinder is Chairman at Partners For Utvecklingsinvesteringar Inom Life Sciences AB.
She is on the Board of Directors at EXINI Diagnostics AB, Hansa Medical AB, Nicox SA, Wingfirm Pharma AB, and Jettesta AB.
Ms. Norinder was previously employed as Independent Director by Karo Bio AB, President & Chief Executive Officer by deCODE genetics, Inc., Independent Non-Executive Director by Antisoma Plc, Chairman & Chief Executive Officer by Prolifix Ltd., Chairman & Chief Executive Officer by Lauras AS, a Director-International Regulatory Affairs by Glaxo Group Research Ltd., a Principal by Pfizer Inc., Senior VP-Worldwide Product Development by Pharmacia & Upjohn, Inc., Vice President-Infection Research & Development by Astra Research Centre AB, and Vice President-Infection Research & Development by Parke-Davis AB.
She also served on the board at Biolipox AB, Photocure ASA, Artimplant AB, InDex Pharmaceuticals AB, MiniDoc AB, and Probi AB.
She received her graduate degree from the University of Uppsala.